Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma
Restricted accessResearch articleFirst published online April, 2017
Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma
Background. We investigated the reliability of combined DOG1 and mammaglobin immunohistochemistry compared with ETV6 fluorescence in situ hybridization (FISH) in the assessment of salivary tumors previously diagnosed as acinic cell carcinoma (ACC). Ultrastructural features of cases reclassified as mammary analogue secretory carcinoma (MASC) were assessed by transmission electron microscopy (TEM). Methods. Immunohistochemical (IHC) reactivity to DOG1 and mammaglobin was validated against FISH targeting the ETV6 gene in all 14 cases. Results. Three cases with papillary cystic histomorphology previously diagnosed as ACC were revised to MASC. TEM features of the ETV6 rearrangement-positive MASC cases showed large numbers of secretory granules with extrusion into the intercellular spaces, well-developed endoplasmic reticulum, lipid-laden vacuoles, well-formed microvilli, and large lining cystic spaces. Conclusions. Combined DOG1 and mammaglobin immunohistochemistry is comparable to ETV6-breakapart analysis for differentiating between papillary cystic variants of ACC and MASC.
CarlsonJLicitraLLocatiLRabenDPerssonFStenmanG. Salivary gland cancer: an update on present and emerging therapies. Am Soc Clin Oncol Educ Book. 2013:257-263.
2.
PerssonMAndrénYMarkJHorlingsHMPerssonFStenmanG. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009;106:18740-18744.
3.
SkalovaAVanecekTSimpsonRHWMichalM. Molecular advances in salivary gland pathology and their practical application. Diagn Histopathol. 2012;18:388-396.
4.
GarciaJJOliveiraAM. Fusion transcripts that characterize malignancies of salivary gland origin. Pathol Case Rev. 2015;20:22-26.
5.
SkálováAVanecekTSimaR. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010:34:599-608.
6.
WangZSpauldingBSienkoA. Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma. Int J Clin Exp Pathol. 2009;2:384-389.
7.
WatsonMAFlemingTP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860-865.
8.
FangerGRHoughtonRLRetterMW. Detection of mammaglobin in the sera of patients with breast cancer. Tumour Biol. 2002;23:212-221.
9.
O’BrienNAO’DonovanNRyanB. Mammaglobin a in breast cancer: existence of multiple molecular forms. Int J Cancer. 2005;114:623-627.
10.
WatsonMADintzisSDarrowCM. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999;59:3028-3031.
11.
ShiCXLongMALiuLGrahamFLGauldieJHittMM. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells. Mol Ther. 2004;10:758-767.
12.
MiettinenMWangZFLasotaJ. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009;33:1401-1408.
13.
FatimaNCohenCSiddiquiMT. DOG1 utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration. Cancer Cytopathol. 2011;119:202-208.
14.
WestRBCorlessCLChenX. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165:107-113.
15.
HemmingerJIwenofuOH. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms. Histopathology. 2012;61:170-177.
16.
LaskawiRRödelRZirkAArglebeC. Retrospective analysis of 35 patients with acinic cell carcinoma of the parotid gland. J Oral Maxillofac. 1998;56:440-443.
17.
EllisGLAuclairPL. Tumors of the Salivary Glands: Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 2008:204-225.
18.
HannaE. Malignant tumors of the salivary gland. In: MyersENSmithMRMyersJHannaE, eds. Cancer of the Head and Neck. 4th ed.Philadelphia, PA. WB Saunders; 2003: 475-510.
19.
LiJGongXXiongP. Ultrasound and computed tomography features of primary acinic cell carcinoma in the parotid gland: a retrospective study. Eur J Radiol. 2014;83:1152-1156.
20.
JamiesonLTaylorSMSmithABullockMJDavisM. Metastatic acinic cell carcinoma of the parotid gland with ectopic ACTH syndrome. Otolaryngol Head Neck Surg. 2007;136:149-150.
21.
SchwarzSZenkJMüllerM. The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis. Histopathology. 2012;61:395-408.
22.
OstmanJAnnerothGGustafssonHTavelinB. Malignant salivary gland tumours in Sweden 1960-1989—an epidemiological study. Oral Oncol. 1997;33:169-176.
23.
LuukkaaHKlemiPLeivoI. Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases. Acta Otolaryngol. 2005;125:207-214.
24.
SchwarzSMullerMEttlTStockmannPZenkJAgaimyA. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Int J Clin Exp Pathol. 2011;4:336-348.
25.
FerlitoABertinoGRinaldoAMannaràGMDevaneyKO. A review of heterotopia and associated salivary gland neoplasms of the head and neck. J Laryngol Otol. 1999;113:299-303.
26.
BironVLLentschEJGerryDRBewleyAF. Factors influencing survival in acinic cell carcinoma: a retrospective survival analysis of 2061 patients. Head Neck. 2015;37:870-877.
27.
PatelNRSanghviSKhanMNHusainQBaredesSEloyJA. Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases. Laryngoscope. 2014;124:172-178.
28.
GeigerJLGarcíaJJPriceKA. Acinic cell carcinoma of the salivary gland with metastatic spread to the pancreas. Case Rep Oncol. 2014;7:195-198.
29.
SessaSZiranuADi GiacomoGGiovanniAMaccauroG. A rare case of iliac crest metastasis from acinic cell carcinoma of parotid gland. World J Surg Oncol. 2014;12:48.
30.
BreenJTCarlsonMLLinkMJMooreEJNeffBADriscollCL. Skull base involvement by acinic cell carcinoma of the parotid gland. J Neurol Surg B Skull Base. 2012;73:371-378.
31.
TriantafillidouKIordanidisFPsomaderisKKalimerasE. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study. J Oral Maxillofac Surg. 2010;68:2489-2496.
32.
TuGHuYJiangPQinD. The superiority of combined therapy (surgery and postoperative irradiation) in parotid cancer. Arch Otolaryngol. 1982;108:710-713.
NeskeyDMKleinJDHicksS. Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013;139:1195-1202.
35.
HoffmanHTKarnellLHRobinsonRAPinkstonJAMenckHR. National Cancer Data Base report on cancer of the head and neck. Head Neck. 1999;21:297-309.
36.
EllisGLSimpsonRHW. Acinic cell carcinoma. In: BarnesLEvesonJWReichartPSidranskyD, eds. Pathology and Genetics of Head and Neck Tumors (WHO Classification of Tumors). Lyon, France: IARC Press; 2005:216-218.
37.
ColmeneroCPatronMSierraI. Acinic cell carcinoma of the salivary glands. A review of 20 new cases. J Craniomaxillofac Surg. 1991;19:260-266.
38.
GiannoniCel-NaggarAKOrdoñezNG. C-erbB-2/neu oncogene and ki67 analysis in the assessment of palatal salivary gland neoplasms. Otolaryngol Head Neck Surg. 1995;112:391-398.
39.
HellquistHBSundelinKDi BaccoA. Tumor growth fraction and apoptosis in salivary gland carcinomas. Prognostic implications of ki67 and bcl-2 expression and of in situ end labeling (TUNEL). J Pathol. 1997;181:323-329.
40.
NaglerRMKernerHBen-EliezerS. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies. Oncology. 2003;64:389-398.
41.
GomezDRKatabiNZhungJ. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer. 2009;115:2128-2137.
42.
SpiroRHHuvosAGStrongEW. Acinic cell carcinoma of salivary origin. Aclinicopathologic study of 67 cases. Cancer. 1978;41:924-935.
43.
LiJGongXXiongP. Ultrasound and computed tomography features of primary acinic cell carcinoma in the parotid gland: a retrospective study. Eur J Radiol. 2014;83:1152-1156.
44.
ChouCZhuGLuoMXueG. Carcinoma of the minor salivary glands: results of surgery and combined therapy. J Oral Maxillofacial Surg. 1996;54:448-453.
45.
MertensFJohanssonBMitelmanF. Isochromosomes in neoplasia. Genes Chromosomes Cancer. 1994;10:221-230.
46.
EttlTSchwarz-FurlanSHaubnerF. The PI3K/ AKT/mTOR signaling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation. Oral Oncol. 2012;48:822-830.
47.
DiegelCRChoKREl-NaggarAKWilliamsBOLindvallC. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma. Cancer Res. 2010;70:9143-9152.
48.
StenmanGPerssonFAnderssonMK. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers. Oral Oncol. 2014;50:683-690.
49.
O’NeillID. t (11; 19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. Oral Oncol. 2009;45:2-9.
SeifertG. Histopathology of malignant salivary gland tumors. Eur J Cancer B Oral Oncol. 1992;28B:49-56.
52.
BatsakisJGLunaMAEl-NaggarAK. Histopathological grading of salivary glands neoplasms: II. Acinic cell carcinomas. Ann Otol Laryngol. 1990;99:1007-1009.
53.
GneppDRHenleyJDSimpsonRHWEvesonJ. Salivary and lacrimal glands. In: GneppDR, ed. Diagnostic Surgical Pathology of the Head and Neck. Philadelphia, PA: Saunders/Elsevier; 2009:471-472.
54.
PerzinKHLiVolsiVA. Acinic cell carcinomas arising in salivary glands: a clinicopathologic study. Cancer. 1979;44:1434-1457.
55.
HenleyJDGearyWAJacksonCLWuCDGneppDR. Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity. Hum Pathol. 1997;28:869-873.
56.
Said-Al-NaiefNKleinMJ. Clear cell entities of the head and neck: a selective review of clear cell tumors of the salivary glands. Head Neck Pathol. 2008;2:111-115.
57.
AuclairPL. Tumor-associated lymphoid proliferation in the parotid gland. A potential diagnostic pitfall. Oral Surg Oral Med Oral Pathol. 1994;77:19-26.
58.
MichalMSkálováASimpsonRHLeivoIRyskaAStárekI. Well-differentiated acinic cell carcinoma of salivary glands associated with lymphoid stroma. Hum Pathol. 1997;28:595-600.
59.
CriveliniMMde SousaSOde AraújoVC. Immunohistochemical study of acinic cell carcinoma of minor salivary gland. Oral Oncol. 1997;33:204-208.
60.
CoppolaDSzaboMBoulwareD. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res. 2004;10:184-190.
61.
BellahceneACastronovoVOgburekeKUFisherLWFedarkoNS. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer. 2008;8:212-226.
62.
WeberGFAshkarSCantorH. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians. 1997;109:1-9.
63.
CookACTuckABMcCarthyS. Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progression. Mol Carcinog. 2005;43:225-236.
64.
FokTCLapointeHTuckAB. Expression and localization of osteopontin, homing cell adhesion molecule/CD44, and integrin αvβ3 in mucoepidermoid carcinoma and acinic cell adenocarcinoma of salivary gland origin. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:320-329.
65.
GneppDR. Salivary gland tumor “wishes” to add to the next WHO Tumor Classification: sclerosing polycystic adenosis, mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and mucinous variant of myoepithelioma. Head Neck Pathol. 2014;8:42-49.
66.
SimpsonRHSkálováADi PalmaSLeivoI. Recent advances in the diagnostic pathology of salivary carcinomas. Virchows Arch. 2014;465:371-384.
67.
GriffithCSeethalaRChioseaSI. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Arch. 2011;459:117-118.
68.
KratochvilFJ3rdStewartJCMooreSR. Mammary analog secretory carcinoma of salivary glands: a report of 2 cases in the lips. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:630-635.
69.
MarianoFVdos SantosHTAzañeroWD. Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification. Histopathology. 2013;63:558-567.
70.
SkálováAVanecekTMajewskaH. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38:23-33.
71.
ChioseaSIGriffithCAssaadASeethalaRR. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36:343-350.
72.
UranoMNagaoTMiyabeSIshibashiKHiguchiKKurodaM. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers. Hum Pathol. 2015;46:94-103.
73.
SamsRNGneppDR. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol. 2012;7:64-68.
74.
GriffithCCStelowEBSaqiA. The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Cancer Cytopathol. 2013;121:234-241.
75.
PatelKRSolomonIHEl-MoftySKLewisJSJrChernockRD. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma. Hum Pathol. 2013;44:2501-2508.
76.
ChildersELEllisGLAuclairPL. An immunohistochemical analysis of anti-amylase antibody reactivity in acinic cell adenocarcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:691-694.
77.
ConnorAPerez-OrdonezBShagoMSkalovaAWeinrebI. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36:27-34.
78.
ChênevertJDuvvuriUChioseaS. DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol. 2012;25:919-29. doi:10.1038/modpathol.2012.57.
79.
NielsenTOWestRBLinnSC. Molecular characterization of soft tissue tumours: a gene expression study. Lancet. 2002;359:1301-1307.
80.
DemetriGDVan OosteromATGarrettCR. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomized controlled trial. Lancet. 2006;368:1329-1333.
81.
KearneyL. Molecular cytogenetics. Best Pract Res Clin Haematol. 2001;14:645-469.
82.
BishopR. Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance. Biosci Horizons. 2010;3:85-95.
83.
AlpárDHermeszJPótóL. Automated FISH analysis using dual-fusion and break-apart probes on paraffin-embedded tissue sections. Cytometry A. 2008;73:651-657.
84.
BarransSLEvansPAO’ConnorSJOwenRGMorganGJJackAS. The detection of t(14;18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. J Mol Diagn. 2003;5:168-175.
85.
VenturaRAMartin-SuberoJIJonesM. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8:141-151.
86.
ItoSIshidaESkalovaAMatsuuraKKumamotoHSatoI. Case report of mammary analog secretory carcinoma of the parotid gland. Pathol Int. 2012;62:149-152.
87.
BellevicineCNatellaVSommaDe RosaAGTronconeG. MASC is indistinguishable from acinic cell carcinoma, papillary-cystic variant on salivary gland FNA cytomorphology: case report with histological and immunohistochemical correlates. Cytopathology. 2014;25:342-348.
88.
AlbusJBatanianJWenigBMVidalCI. A unique case of a cutaneous lesion resembling mammary analog secretory carcinoma: a case report and review of the literature. Am J Dermatopathol. 2015;37:e41-e44.
89.
BrandtSMSwistelAJRosenPP. Secretory carcinoma in the axilla: probable origin from axillary skin appendage glands in a young girl. Am J Surg Pathol. 2009;33: 950-953.
90.
KazakovDVHantschkeMVanecekTKacerovskaDMichalM. Mammary-type secretory carcinoma of the skin. Am J Surg Pathol. 2010;34:1226-1227.
91.
van de RijnMGuoXSweeneyRTBeckAHWestRB. Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities. Histopathology. 2014;64:163-170.
92.
EchevarriaRA. Ultrastructure of the acinic cell carcinoma and clear cell carcinoma of the parotid gland. Cancer. 1967;20:563-571.
93.
FooteFWFrazellEL. Tumors of the major salivary glands. Cancer. 1953;6:1065-1133.
94.
AkhtarMRobinsonCAliMAGodwinJT. Secretory carcinoma of the breast in adults. Light and electron microscopic study of three cases with review of the literature. Cancer. 1983;51:2245-2254.
95.
JoshiPMridhaARSinghSKinraPRayRThakarA. Large lipid-rich mammary analogue secretory carcinoma of parotid gland: an unusual case. Indian J Pathol Microbiol. 2015;58:351-353.
